Showing results (1-10 of 378) with videos related to
Sort By:
Pageof 38
Trends in Cancer|June 17, 2025
STEAP1: a promising target in prostate cancer therapyRohit Singh, Jon Amund KyteCancers|February 15, 2022
Strategies for Improving the Efficacy of CAR T Cells in Solid CancersJon Amund KyteExpert Review of Vaccines|January 30, 2010
Third International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD 2009)Jon Amund KyteTidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 23, 2006
[Cancer vaccines]Jon Amund KyteExpert Opinion on Investigational Drugs|April 25, 2009
Cancer vaccination with telomerase peptide GV1001Jon Amund KyteMethods in Molecular Biology (Clifton, N.J.)|February 2, 2020
Use of RNA Interference with TCR Transfer to Enhance Safety and EfficiencyNicholas Paul Casey, Jon Amund Kyte, Hiroshi FujiwaraOncoimmunology|March 26, 2019
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccinationJon Amund Kyte, Anne Fåne, Martin Pule, et al.BMC Research Notes|April 24, 2025
Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cellsNiladri Bhusan Pati, Yixin Jin, Suman Kumar, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2026
Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trialHanne Astrid Eide, Harald Grut, Peter Jebsen, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2015
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccinationGaute Lund Hansen, Gustav Gaudernack, Paal Fredrik Brunsvig, et al.Pageof 38